BIOTECHNOLOGY-INDUSTRY

BIOTECHNOLOGY-INDUSTRY

Analyst Expectations For Biomarin Pharmaceutical's Future

Introduction BioMarin Pharmaceutical, a leading biotechnology company focused on developing treatments for rare genetic disorders, has been the subject of intense scrutiny from analysts over the past few months. The company's recent performance, including its earnings reports and pipeline updates, has sparked a wide range of reactions from the investment community..

BIOTECHNOLOGY-INDUSTRY

Genentech executive Fritz Bittenbender: Beware political soundbites

As Election Day draws near, the biotech industry is grappling with pressing issues that could significantly impact its future..